NMD-inhibition by siRNA targeting of NMD regulatory genes SMG1 or UPF2 has recently been shown capable of inducing protective in vivo immune responses to tumour cells transfected with an NMD-sensitive target antigen[41]. This evidence concerns the gene UPF2 and neoplasm.